Reduction of Newcastle Disease Vaccine Dose Using a Novel Adjuvant for Cellular Immune Response in Poultry
Authors:
- J. Ben ArousJAJ. Ben Arous
- S. DevilleSDS. Deville
- J.K. PalJPJ.K. Pal
- S. BaksiSBS. Baksi
- F. BertrandFBF. Bertrand
- L. DupuisLDL. Dupuis
Open Access
- 1 January 2013
- journal article
- Published by Elsevier in Procedia in Vaccinology
- Vol. 7, 28-33
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickensVaccine, 2012
- Montanide™ ISA 71 VG adjuvant enhances antibody and cell-mediated immune responses to profilin subunit antigen vaccination and promotes protection against Eimeria acervulina and Eimeria tenellaExperimental Parasitology, 2011
- Immunoenhancing effects of Montanide™ ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infectionVeterinary Parasitology, 2010
- Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challengeVaccine, 2007
- Adjuvants designed for veterinary and human vaccinesVaccine, 2001